Cargando…
A Real-World Data Study on the Healthcare Resource Use for Uncontrolled Moderate-to-Severe Atopic Dermatitis in Secondary Care in the United Kingdom Prior to the Introduction of Biologic Treatment
BACKGROUND: Whilst there is international evidence around the high healthcare resource utilization (HRU) associated with atopic dermatitis (AD), there is a lack of published data from the United Kingdom (UK). METHODS: A retrospective, descriptive, observational study was conducted to evaluate the bu...
Autores principales: | Hudson, Richard D A, Ameen, Mahreen, George, Susannah M C, Harwood, Catherine A, Weller, Richard B, Lear, John T, Rout, Rajesh, Surendranathan, Thishi, Petrovic, Milos, Bewley, Anthony P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992740/ https://www.ncbi.nlm.nih.gov/pubmed/35399649 http://dx.doi.org/10.2147/CEOR.S333847 |
Ejemplares similares
-
Process utilities for topical treatment in atopic dermatitis
por: Retzler, Jenny, et al.
Publicado: (2019) -
Dupilumab Provides Significant Clinical Benefit in a Phase 3 Trial in Adolescents with Uncontrolled Atopic Dermatitis Irrespective of Prior Systemic Immunosuppressant Use
por: DELEURAN, Mette, et al.
Publicado: (2021) -
Perception and Experience of Biologic Therapy in Atopic Dermatitis: A Qualitative Focus Group Study of Physicians and Patients in Europe and Canada
por: Ameen, Mahreen, et al.
Publicado: (2021) -
Atopic dermatitis epidemiology and unmet need in the United Kingdom
por: Cork, Michael J., et al.
Publicado: (2019) -
The dynamics of the manifestations of atopic dermatitis in severe persistent uncontrolled asthma children with omalizumab therapy
por: Vishneva, Elena, et al.
Publicado: (2015)